Gsa Capital Partners LLP Fulgent Genetics, Inc. Transaction History

Gsa Capital Partners LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$19.09 - $22.57 $769,766 - $910,090	40,323 New	40,323 $791,000
Q3 2023 Nov 15, 2023	BUY	$26.74 - $40.81 $658,766 - $1.01 Million	24,636 New	24,636 $658,000
Q1 2021 May 10, 2021	SELL	$59.3 - $183.85 $247,162 - $766,286	-4,168 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$31.01 - $52.1 $129,249 - $217,152	4,168 New	4,168 $217,000
Q2 2020 Aug 11, 2020	SELL	$8.89 - $18.28 $89,869 - $184,792	-10,109 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$6.75 - $19.75 $70,814 - $207,197	-10,491 Reduced 50.93%	10,109 $109,000
Q4 2019 Feb 12, 2020	BUY	$9.29 - $15.82 $191,373 - $325,892	20,600 New	20,600 $266,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.